# Impact of Palmitoylethanolamide (PEA) in the Management of Oro-facial Pain

> **NCT05877170** · NA · UNKNOWN · sponsor: **University of Catania** · enrollment: 40 (estimated)

## Conditions studied

- Oral-facial Pain

## Interventions

- **DIETARY_SUPPLEMENT:** Palmitoyletinolamide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05877170
- **Lead sponsor:** University of Catania
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-18
- **Primary completion:** 2023-08-12
- **Final completion:** 2023-08-17
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05877170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05877170, "Impact of Palmitoylethanolamide (PEA) in the Management of Oro-facial Pain". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05877170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*